Ausgabe 7/2022
Inhalt (10 Artikel)
PARP Inhibition, a New Therapeutic Avenue in Patients with Prostate Cancer
Ronan Flippot, Anna Patrikidou, Mihaela Aldea, Emeline Colomba, Pernelle Lavaud, Laurence Albigès, Natacha Naoun, Pierre Blanchard, Mario Terlizzi, Camilo Garcia, Alice Bernard-Tessier, Alina Fuerea, Mario Di Palma, Bernard Escudier, Yohann Loriot, Giulia Baciarello, Karim Fizazi
Lupus Nephritis: Improving Treatment Options
Myrto Kostopoulou, Sofia Pitsigavdaki, George Bertsias
New Drug Delivery Systems Developed for Brain Targeting
Shruti U. Rawal, Bhoomika M. Patel, Mayur M. Patel
Adverse Events Associated with Immune Checkpoint Inhibitors: Overview of Systematic Reviews
Salmaan Kanji, Sydney Morin, Kyla Agtarap, Debanjali Purkayastha, Pierre Thabet, Dominick Bosse, Xiang Wang, Carole Lunny, Brian Hutton
Correction to: Benefits and Harms of ‘Smart Drugs’ (Nootropics) in Healthy Individuals
Fabrizio Schifano, Valeria Catalani, Safia Sharif, Flavia Napoletano, John Martin Corkery, Davide Arillotta, Suzanne Fergus, Alessandro Vento, Amira Guirguis